TC
Texas Capital Bancshares, Inc.
TCBIO · NASDAQ
$19.68 -0.25% (-$0.05)
1M -4.23%
Market Cap $877.4M
P/E Ratio 2.41x
Div. Yield 7.30%
ROE 10.04%
Bulios Fair Price
$24.49
24.4% upside
Current Price
$19.68
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TCBIO is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
100 /100
Cheap P/E 2.41x
P/S 0.45x
P/B 0.24x
Growth
65 /100
Stable EPS growth 3.24%
Rev. growth 17.09%
Book val. growth 5.93%
Profitability
72 /100
Strong Net margin 18.58%
Op. margin 24.85%
Gross margin N/A
Quality
66 /100
Average ROE 10.04%
ROA 1.08%
Asset turnover 0.06x
Debt
100 /100
Low Current ratio 26.12x
Debt/Equity N/A
Int. coverage N/A
Stability
48 /100
Moderate Beta 0.67x
Rev. volatility 23.20%
EPS volatility 279.94%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TCBIO
Online
Sector
Financial Services
Industry
Banks - Regional
CEO
Robert C. Holmes
Employees
1,785
Headquarters
Dallas
Upcoming events
21 OCT
Earnings
Upcoming earnings report